191 related articles for article (PubMed ID: 8601421)
1. Human HepG2 and rat Fao hepatic-derived cell lines show different responses to ciprofibrate, a peroxisome proliferator: analysis by flow cytometry.
Passilly P; Jannin B; Hassell SJ; Latruffe N
Exp Cell Res; 1996 Mar; 223(2):436-42. PubMed ID: 8601421
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
Duclos S; Bride J; Ramirez LC; Bournot P
Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
[TBL] [Abstract][Full Text] [Related]
3. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
Perrone CE; Shao L; Williams GM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
[TBL] [Abstract][Full Text] [Related]
4. Difference between guinea pig and rat in the liver peroxisomal response to equivalent plasmatic level of ciprofibrate.
Pacot C; Petit M; Rollin M; Behechti N; Moisant M; Deslex P; Althoff J; Lhuguenot JC; Latruffe N
Arch Biochem Biophys; 1996 Mar; 327(1):181-8. PubMed ID: 8615689
[TBL] [Abstract][Full Text] [Related]
5. Differences in cell proliferation in rodent and human hepatic derived cell lines exposed to ciprofibrate.
Clemencet MC; Muzio G; Trombetta A; Peters JM; Gonzalez FJ; Canuto RA; Latruffe N
Cancer Lett; 2005 May; 222(2):217-26. PubMed ID: 15863271
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of peroxisomal palmitoyl-CoA oxidase activity by ciprofibrate in hepatic cell lines: comparative studies in Fao, MH1C1 and HepG2 cells.
Brocard C; Es-Souni M; Ramirez LC; Latruffe N; Bournot P
Biol Cell; 1993; 77(1):37-41. PubMed ID: 8390885
[TBL] [Abstract][Full Text] [Related]
7. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes.
Hong JT; Glauert HP
J Cell Physiol; 1996 Nov; 169(2):309-19. PubMed ID: 8908198
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes.
Ammerschlaeger M; Beigel J; Klein KU; Mueller SO
Toxicol Sci; 2004 Apr; 78(2):229-40. PubMed ID: 14976357
[TBL] [Abstract][Full Text] [Related]
9. Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.
Yadetie F; Laegreid A; Bakke I; Kusnierczyk W; Komorowski J; Waldum HL; Sandvik AK
Physiol Genomics; 2003 Sep; 15(1):9-19. PubMed ID: 12851464
[TBL] [Abstract][Full Text] [Related]
10. Properties of peroxisomes from jerboa (Jaculus orientalis).
el Kebbaj MS; Cherkaoui Malki M; Latruffe N
Eur J Cell Biol; 1996 Jun; 70(2):150-6. PubMed ID: 8793387
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of clofibrate on peroxisomal enzymes of human (Hep EBNA2) and rat (FaO) hepatoma cell lines.
Scotto C; Keller JM; Schohn H; Dauça M
Eur J Cell Biol; 1995 Apr; 66(4):375-81. PubMed ID: 7656903
[TBL] [Abstract][Full Text] [Related]
12. Influence of peroxisome proliferators on phosphoprotein levels in human and rat hepatic-derived cell lines.
Passilly P; Jannin B; Latruffe N
Eur J Biochem; 1995 May; 230(1):316-21. PubMed ID: 7601116
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
Rao MS; Lalwani ND; Watanabe TK; Reddy JK
Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines.
Goll V; Viollon-Abadie C; Nicod L; Richert L
Hum Exp Toxicol; 2000 Mar; 19(3):193-202. PubMed ID: 10889518
[TBL] [Abstract][Full Text] [Related]
15. Effects of two peroxisome proliferators (ciprofibrate and fenofibrate) on peroxisomal membrane proteins and dihydroxyacetone-phosphate acyl-transferase activity in rat liver.
Causeret C; Bentejac M; Clemencet MC; Bugaut M
Cell Mol Biol (Noisy-le-grand); 1993 Feb; 39(1):65-80. PubMed ID: 8467241
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate.
Passilly P; Schohn H; Jannin B; Cherkaoui Malki M; Boscoboinik D; Dauça M; Latruffe N
Biochem Pharmacol; 1999 Sep; 58(6):1001-8. PubMed ID: 10509752
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective effects of chiral clofibric acid analogs on rat peroxisome proliferator-activated receptor alpha (rPPAR alpha) activation and peroxisomal fatty acid beta-oxidation.
Rangwala SM; O'Brien ML; Tortorella V; Longo A; Loiodice F; Noonan DJ; Feller DR
Chirality; 1997; 9(1):37-47. PubMed ID: 9094202
[TBL] [Abstract][Full Text] [Related]
18. Differential action of 13-HPODE on PPARalpha downstream genes in rat Fao and human HepG2 hepatoma cell lines.
König B; Eder K
J Nutr Biochem; 2006 Jun; 17(6):410-8. PubMed ID: 16216487
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
Goll V; Alexandre E; Viollon-Abadie C; Nicod L; Jaeck D; Richert L
Toxicol Appl Pharmacol; 1999 Oct; 160(1):21-32. PubMed ID: 10502499
[TBL] [Abstract][Full Text] [Related]
20. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator.
Kasai H; Okada Y; Nishimura S; Rao MS; Reddy JK
Cancer Res; 1989 May; 49(10):2603-5. PubMed ID: 2713844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
